|
Appendix
3D Systems Corporation Unaudited Reconciliations of GAAP to Non-GAAP Measures Three Months Ended December 31, 2023 and 2022 . | ||||||||||||||||||
| Constant Currency Revenue (4) | ||||||||||||||||||
| Three Months Ended December 31, | Constant Currency (1) | |||||||||||||||||
| (in thousands) | 2023 | 2022 | $ Change | % Change | FX Effect (2) | % Change (3) | ||||||||||||
| Healthcare Solutions | $ | 51,188 | $ | 60,694 | $ | (9,506 | ) | (15.7 | )% | $ | 454 | (16.4 | )% | |||||
| Industrial Solutions | 63,660 | 72,038 | (8,378 | ) | (11.6 | )% | 1,196 | (13.3 | )% | |||||||||
| Total revenue | $ | 114,848 | $ | 132,732 | $ | (17,884 | ) | (13.5 | )% | $ | 1,650 | (14.7 | )% | |||||
|
3D Systems Announces Final 2023 Financial Results and Dates for Q1 and Q2 2024 Earnings Releases
(a) The amounts for cash and cash equivalents shown above include restricted cash of $119, $114 and $313 as of December 31, 2023, 2022 and 2021, respectively, which are included in prepaid expenses and other current assets. In addition, included in cash and cash equivalents above as of December 31, 2023 and 2022 is $1,467 and $3,727 of restricted cash, which, is included in other non-current assets.
|
|
||||||
|
|
|||||||
|
|||||||
